MENU
TCRT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alaunos Therapeutics (TCRT) Ownership - Who owns Alaunos Therapeutics?

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease)... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
2617 Bissonnet Street
Phone
+1 346 355-4099
Employees
1
Web
https://www.alaunos.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.08M
P/E Ratio
N/A
Total Cash
354K
Projected Growth
N/A
Total Debt
N/A
Revenue
3K
Risk (Beta)
1.57
Dividend Yield
N/A
Total Cash/Share
0.14
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
TCRT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a cancer treatment company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
2617 Bissonnet Street
Phone
+1 346 355-4099
Employees
1
Web
https://www.alaunos.com